Table of Content


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers:
4.1.1.1. Rising prevalence of infectious diseases worldwide
4.1.1.2. Increasing demand for home-based lateral flow assay devices
4.1.1.3. Growing demand for point-of-care testing
4.1.2. Restraints:
4.1.2.1. Reluctance towards changing existing diagnostic practices
4.1.2.2. Implementation of excise duty on medical devices in the U.S.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Product Innovations
5.6. Unmet Needs
6. By Product
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
6.1.2. Market Attractiveness Index, By Product Segment
6.2. Kits & Reagents
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.3. Lateral Flow Readers
6.3.1. Digital/Mobile Readers
6.3.2. Benchtop Readers
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
7.1.2. Market Attractiveness Index, By Application Segment
7.2. Veterinary Diagnostics
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Drug Development & Quality Testing
7.4. Food Safety & Environmental Safety
7.5. Clinical Testing
7.6. Pregnancy & Fertility Testing
7.6.1. Fertility Testing
7.6.2. Pregnancy Testing
7.7. Cardiac Markers
7.7.1. CK-MB Testing
7.7.2. Myoglobin Testing
7.7.3. BNP or NT-proBNP Testing
7.7.4. Troponin I and T Testing
7.7.5. D-Dimer Testing
7.7.6. Other Cardiac Marker Testing
7.8. Infectious Diseases Testing
7.8.1. Mosquito-borne Disease Testing
7.8.2. Tuberculosis Testing
7.8.3. Sexually Transmitted Infection Testing
7.8.4. HIV Testing
7.8.5. Gonorrhea Testing
7.8.6. Chlamydia Testing
7.8.7. HPV Testing
7.8.8. Syphilis Testing
7.8.9. Other STI Testing
7.8.10. Influenza Testing
7.8.11. Hepatitis Testing
7.8.12. Other Infectious diseases
7.9. Drugs of Abuse Testing
7.10. Cholesterol/Lipid Testing
7.11. Other Clinical Tests
8. By Technique
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique Segment
8.1.2. Market Attractiveness Index, By Technique Segment
8.2. Sandwich Assays
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Competitive Assays
8.4. Multiplex Detection Assays
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
9.1.2. Market Attractiveness Index, By End User Segment
9.2. Biotechnology & Pharmaceutical Companies
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Hospitals and Clinics
9.4. Diagnostic Laboratories
9.5. Home Care
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.2.6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.7. U.S.
10.2.8. Canada
10.2.9. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.4.1.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.3.5.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6. Germany
10.3.7. U.K.
10.3.8. France
10.3.9. Italy
10.3.10. Spain
10.3.11. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.4.6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.7. Brazil
10.4.8. Argentina
10.4.9. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.2.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.3.1.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.5.4.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.5. China
10.5.6. India
10.5.7. Japan
10.5.8. Australia
10.5.9. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Types Benchmarking
11.4. List of Key Companies to Watch
12. Company Profiles
12.1. QIAGEN
12.1.1. Company Overview
12.1.2. Product Type Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. F. Hoffmann-La Roche AG
12.3. Bio-Rad Laboratories, Inc.
12.4. ABBOTT Laboratories
12.5. Siemens AG
12.6. Danaher Corporation
12.7. Becton, Dickinson and Company
12.8. Merck KGaA
12.9. Thermo Fisher Scientific Inc.
12.10. Hologic Inc.
LIST NOT EXHAUSTIVE
13. Global Lateral Flow Assay Market – DataM
13.1. Appendix
13.2. About Us and End User
13.3. Contact Us